Overview
Marco Mielcarek is an Oncologist in Seattle, Washington. Dr. Mielcarek has been practicing medicine for over 35 years is highly rated in 6 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Chronic B-Cell Leukemia (CBCL).
His clinical research consists of co-authoring 79 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- PPO
- PPO
- EPO
- PPO
Locations
825 Eastlake Ave E, Seattle, WA 98109
1959 NE Pacific St, Seattle, WA 98195
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Rachel Loschiavo PA-C
Ajay Gopal is an Oncologist in Seattle, Washington. Dr. Gopal is highly rated in 22 conditions, according to our data. His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and Classical Hodgkin Lymphoma.
Swedish Cardiovascular RSRCH
John Pagel is an Oncologist in Seattle, Washington. Dr. Pagel is highly rated in 19 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Gme Office University Of Washington
Bart Scott is an Oncologist in Seattle, Washington. Dr. Scott is highly rated in 13 conditions, according to our data. His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Leukemia, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Marco Mielcarek
How do I make an appointment with Dr. Marco Mielcarek?
You can book an appointment with Dr. Marco Mielcarek by calling their office at 206-288-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Marco Mielcarek a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marco Mielcarek is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Marco Mielcarek specialize in?
While Dr. Marco Mielcarek is a Oncology, they have specific expertise in Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Acute Myeloblastic Leukemia without Maturation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Marco Mielcarek participate in research or clinical trials?
Yes. Dr. Marco Mielcarek has published 79 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Marco Mielcarek's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Marco Mielcarek accept my insurance?
Dr. Marco Mielcarek accepts most major insurance plans, including HMSA and PacificSource. We recommend calling the office directly at 206-288-1000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without MaturationDr. Mielcarek isDistinguished. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Mielcarek isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Myelodysplastic Syndrome (MDS)Dr. Mielcarek isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Childhood Acute Myeloid LeukemiaDr. Mielcarek isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Mielcarek isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Mielcarek isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Mielcarek isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- AgranulocytosisDr. Mielcarek isExperienced. Learn about Agranulocytosis.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Mielcarek isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Mielcarek isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Febrile NeutropeniaDr. Mielcarek isExperienced. Learn about Febrile Neutropenia.